This topic contains a solution. Click here to go to the answer

Author Question: A patient is taking cefadroxil (Duricef) and comes to the clinic complaining of loose stools for ... (Read 28 times)

olgavictoria

  • Hero Member
  • *****
  • Posts: 528
A patient is taking cefadroxil (Duricef) and comes to the clinic complaining of loose stools for several days. The primary care NP notes normal vital signs; warm, pink skin with elastic turgor; and moist mucous membranes. The NP should:
 
  a. order tests for Clostridium difficileassociated disease (CDAD).
  b. discontinue the cefadroxil.
  c. reassure the patient that loose stools are common with antibiotics.
  d. recommend consuming lactobacillus-containing foods to minimize diarrhea.

Question 2

A 12-month-old child with severe developmental delays was recently treated in an emergency department for a febrile seizure and is seen by the primary care NP for a follow-up visit.
 
  The child's parent asks if it is necessary to continue giving the child phenobarbital. The NP should tell the parent that: a. the phenobarbital may be used on an as-needed basis.
  b. the phenobarbital may be stopped when an EEG is normal.
  c. once the febrile illness is past, the phenobarbital may be stopped.
  d. their child is at increased risk for seizures and should continue the phenobarbital.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ecox1012

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

A
The U.S. Food and Drug Administration (FDA) advises that CDAD be considered in all patients who present with diarrhea after antibiotic use. This patient's symptoms are mild, so discontinuation of the drug is not warranted unless CDAD is present.

Answer to Question 2

D
Although the American Academy of Pediatrics has concluded that the risks of long-term treatment with phenobarbital outweigh the potential benefits in most cases, continued treatment with this drug is used in children at greatest risk for future neurologic problems, including children with febrile seizures before 18 months of age and children with neurologic dysfunction or severe developmental delays.




olgavictoria

  • Member
  • Posts: 528
Reply 2 on: Jul 24, 2018
:D TYSM


pratush dev

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

For a complete list of videos, visit our video library